Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Theriva Biologics, Inc. (TOVX) had Operating Cash Flow per Share of $-0.06 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.30M |
|
$-2.04M |
|
-- |
|
$0.30M |
|
$2.43M |
|
$-2.13M |
|
$0.08M |
|
$-2.04M |
|
$-2.04M |
|
$-2.04M |
|
$-2.04M |
|
$-2.04M |
|
$-2.04M |
|
$-2.13M |
|
$-2.10M |
|
41.07M |
|
41.07M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$16.76M |
|
$0.19M |
|
$21.49M |
|
$38.25M |
|
$10.26M |
|
$1.63M |
|
$12.59M |
|
$22.85M |
|
$15.40M |
|
$15.40M |
|
$15.40M |
|
45.89M |
|
| Cash Flow Statement Financials | |
$-2.46M |
|
-- |
|
$3.87M |
|
$13.10M |
|
$14.48M |
|
$1.37M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.63 |
|
-- |
|
-- |
|
0.10 |
|
0.11 |
|
100.00% |
|
-709.00% |
|
-709.00% |
|
-- |
|
-681.33% |
|
-681.33% |
|
$-2.46M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.02 |
|
4838.10 |
|
-13.27% |
|
-13.27% |
|
-5.34% |
|
-12.01% |
|
$0.34 |
|
$-0.06 |
|
|
Operating Cash Flow per Share |
$-0.06 |